BsUFA III: Reauthorization Process Begins With US FDA Considering Staffing, Uptake Issues

 
• By Derrick Gingery
  
FDA entrance sign 2016
The virtual BsUFA III kick-off meeting is scheduled for 9 a.m. to 12:30 p.m. on 19 November.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics